Jaguar Health, Inc. (JAGX)
USD 0.86
(-8.51%)
USD 0.86
(-8.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.76 Million | 11.95 Million | 4.33 Million | 9.38 Million | 5.77 Million | 4.41 Million |
| Cost of Revenue | 2.03 Million | 2.01 Million | 2.33 Million | 3.28 Million | 3.81 Million | 2.76 Million |
| Gross Profit | 7.72 Million | 9.93 Million | 2 Million | 6.1 Million | 1.95 Million | 1.65 Million |
| Operating Expenses | 42.01 Million | 44.35 Million | 41.07 Million | 27.4 Million | 26.9 Million | 27.26 Million |
| Selling, General and Administrative Expenses | 23.04 Million | 26.7 Million | 25.99 Million | 20.99 Million | 20.43 Million | 22.1 Million |
| Research and Development Expenses | 18.59 Million | 17.64 Million | 15.07 Million | 6.41 Million | 5.81 Million | 5.15 Million |
| Other Expenses | 371 Thousand | 950 Thousand | -765 Thousand | 190 Thousand | 648.8 Thousand | 315.69 Thousand |
| Cost and Expenses | 44.05 Million | 46.37 Million | 43.4 Million | 30.68 Million | 30.72 Million | 30.02 Million |
| Operating Income | -34.29 Million | -34.41 Million | -39.07 Million | -21.3 Million | -24.94 Million | -30.82 Million |
| Interest Expense | 6.38 Million | 12.72 Million | 8.42 Million | 2.79 Million | 5.73 Million | 2.62 Million |
| Income Tax Expense | - | -941 Thousand | 7.65 Million | 2.98 Million | 10 Thousand | -1.27 Million |
| Earnings before Tax | -41.9 Million | -48.39 Million | -52.6 Million | -33.8 Million | -38.52 Million | -32.14 Million |
| Net Income | -41.3 Million | -47.45 Million | -60.25 Million | -36.79 Million | -38.53 Million | -32.14 Million |
| Earnings Per Share Basic | -107.42 | -36.18 | -101.07 | -214.22 | -1746.39 | -15.5 Thousand |
| Earnings Per Share Diluted | -107.42 | -36.18 | -101.07 | -214.22 | -1746.39 | -15.5 Thousand |
| Weighted Average Shares Outstanding | 384.47 Thousand | 1.31 Million | 596.15 Thousand | 171.74 Thousand | 22.06 Thousand | 2073.00 |
| Weighted Average Shares Outstanding (Diluted) | 384.47 Thousand | 1.31 Million | 596.15 Thousand | 171.74 Thousand | 22.06 Thousand | 2073.00 |
| Gross Margin | 0.79 | 0.83 | 0.46 | 0.65 | 0.34 | 0.37 |
| EBIT Margin | -3.39 | -2.61 | -9.15 | -2.58 | -3.97 | -4.55 |
| Profit Margin | -4.23 | -3.97 | -13.90 | -3.92 | -6.67 | -7.28 |
| EBITDA | -33.13 Million | -33.38 Million | -42.35 Million | -28.73 Million | -30.87 Million | -27.76 Million |
| Earnings Before Tax Margin | -3.51 | -2.88 | -9.01 | -2.27 | -4.32 | -6.98 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.72 Million | 2.35 Million | 2.3 Million | 9.76 Million | 2.81 Million | 2.67 Million |
| Cost of Revenue | 986 Thousand | 1.04 Million | 1.27 Million | 4.42 Million | 514 Thousand | 491 Thousand |
| Gross Profit | 1.73 Million | 1.31 Million | 1.02 Million | 5.33 Million | 2.29 Million | 2.18 Million |
| Operating Expenses | 8.93 Million | 9.52 Million | 8.2 Million | 39.25 Million | 11.08 Million | 10.28 Million |
| Selling, General and Administrative Expenses | 5.27 Million | 5.21 Million | 4.74 Million | - | 5 Million | 6.01 Million |
| Research and Development Expenses | 3.65 Million | 4.31 Million | 3.46 Million | - | 6.08 Million | 4.27 Million |
| Other Expenses | -729 Thousand | 234 Thousand | 371 Thousand | 371 Thousand | -70 Thousand | 26 Thousand |
| Cost and Expenses | 9.91 Million | 10.56 Million | 9.48 Million | 43.68 Million | 11.6 Million | 10.77 Million |
| Operating Income | -7.19 Million | -8.21 Million | -7.18 Million | -33.92 Million | -8.78 Million | -8.1 Million |
| Interest Expense | 108 Thousand | 611 Thousand | 248 Thousand | -6.38 Million | 500 Thousand | 3.45 Million |
| Income Tax Expense | -136 Thousand | -142 Thousand | -139 Thousand | -601 Thousand | 304 Thousand | -141 Thousand |
| Earnings before Tax | -9.62 Million | -9.36 Million | -9.3 Million | -41.9 Million | -7.9 Million | -12.29 Million |
| Net Income | -9.49 Million | -9.22 Million | -9.17 Million | -41.3 Million | -7.77 Million | -12.15 Million |
| Earnings Per Share Basic | -4.04 | -3.48 | -0.40 | - | -0.38 | -0.69 |
| Earnings Per Share Diluted | -4.04 | -3.48 | -0.40 | - | -0.38 | -0.42 |
| Weighted Average Shares Outstanding | 2.34 Million | 2.64 Million | 23.06 Million | 384.47 Thousand | 20.73 Million | 17.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.34 Million | 2.64 Million | 23.06 Million | 384.47 Thousand | 20.73 Million | 29.1 Million |
| Gross Margin | 0.64 | 0.56 | 0.44 | 0.55 | 0.82 | 0.82 |
| EBIT Margin | -2.44 | -3.23 | -2.87 | - | -2.93 | -2.79 |
| Profit Margin | -3.49 | -3.92 | -3.99 | -4.23 | -2.77 | -4.54 |
| EBITDA | -6.63 Million | -7.6 Million | -6.59 Million | - | -8.23 Million | -7.45 Million |
| Earnings Before Tax Margin | -2.64 | -3.49 | -3.12 | -3.48 | -3.12 | -3.03 |
0332
1165
ALNT
IIPR
6183
WPDPF